EMCDDA Home
  • EN
Search

27–28 June 2013, Lisbon

Third international multi-disciplinary forum on new drugs

Leading European and international experts will meet in Lisbon from 27–28 June for the Third international multidisciplinary forum on new drugs, jointly organised by the EMCDDA and Europol. The event follows on from the Second interdisciplinary forum on new and emerging psychoactive substances held in Palm Springs in June 2012, which focused on the global nature of the phenomenon and the importance of international cooperation in this area. It will also build on the results of the First international multidisciplinary forum on new drugs held in Lisbon in May 2011. This inaugural event aimed to ‘take stock of the current state of the art in the area of new drugs, anticipate future challenges and identify common anchor points that can inform our future actions’.

Significant developments in this field since the 2011 forum have seen it evolve into a complex challenge for scientists, law enforcement and policy makers. This year, experts from a wide range of disciplines will be invited to discuss global developments in the new drugs field including emerging trends and pioneering legislative approaches.

In the wake of the significant increase in the number of new psychoactive substances notified in the EU, this year’s forum will focus on methods and mechanisms to monitor new substances and emerging trends. Given the current economic climate, the event will explore, among others, how centralised efforts can provide added value at national level.

The forum will be held in conjunction with the 13th Annual meeting of the Reitox early warning system network and the Europol second law-enforcement meeting on new psychoactive substances.

Participant area log in (password required)  »

Documents

Full programme

Speech by Wolfgang Götz, EMCDDA Director, 27.06.2013, Lisbon

Photos on Flickr

News and related links

Over 100 specialists from across the globe to review international developments in new drugs field (News release No 9/2013)

New drugs cause fundamental shift in Europe’s drug market (News release No 5/2013)

New drugs in Europe: EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (2013)

Action on new drugs web page

Synthetic cannabinoids in Europe

Legal approaches to controlling new psychoactive substances

 

 

Page last updated: Friday, 28 June 2013